Dr. Karan Sood

@QuantumOnc

Mumbai, India Joined May 2016

7.3K Following 1.2K Followers 1K Posts

Latest posts 5

Pinned post

Dr. Karan Sood @QuantumOnc Jun 25

Oncology education in LMICs is changing — and the group chat is not just a group chat anymore. In our @JCOGO_ASCO paper, we surveyed 202 oncology professionals across 13 countries. Key signals:
📌 61% used X/Twitter as their primary oncology information source. 1/8

Dr. Karan Sood @QuantumOnc Jun 25

Fresh off the press

View quoted post on X

Dr. Karan Sood @QuantumOnc 6d

Most of what we know about lung cancer is discovered in academic centres. Most patients with lung cancer are treated in community setting. My @OncoDaily session is about that gap. One number has stayed with me. 65% of patients with still do not receive appropriate therapy.

OncoDaily Verified account @oncodaily 6d

A biomarker result that comes too late can still lead to the wrong first treatment.

At COGC 2026, Dr. Karan Sood (@QuantumOnc) of ACTREC, Tata Memorial Centre, discussed why lung cancer testing has to be early, broad, and fast enough to actually guide care.

“If the molecular testing is pending, one should wait.”

Read more: oncodaily.com/dialogues/kara…

@TataMemorial

View quoted post on X

Dr. Karan Sood @QuantumOnc 6d

The ASCO Medical Oncology ITE was more than an exam, it was a learning compass.

In this ASCO Connection piece, I reflect on how formative feedback can reshape oncology training, especially in an Indian context where written exams often dominate.

connection.asco.org/do/asco-medica…

connection.asco.org The ASCO Medical Oncology In-Training Examination as a Catalyst for Learning: Reflections for an... Dr. Karan Sood examines what the ASCO Medical Oncology In-Training Examination actually tests, what it cannot, and how fellows can translate their feedback into a focused, realistic, 6-month study pla

ASCO @ASCO 6d

Dr. @QuantumOnc examines how fellows in an Indian training context can translate their feedback from the ASCO Medical Oncology In-Training Examination (MedOnc ITE) into a focused, realistic, 6-month study plan.

Read more: bit.ly/3WQ333K
#ASCOConnection

View quoted post on X

Dr. Karan Sood @QuantumOnc Oct 16

What a wonderful time i had with Dr El-Deiry. Thank you for the warm hospitality!

Wafik S. El-Deiry, MD, PhD, FACP Verified account @weldeiry Oct 16

I said good bye to Dr. Karan Sood at Logan Airport this afternoon as he heads back to Mumbai, India. The time he spent with us at @BrownUniversity and @BrownUnivHealth as a @WINConsortium Precision Oncology Fellow was productive and sets the stage for future work and collaboration. @Dr_R_Kurzrock @SewantiLimaye @LiaTsimberidou @VivekSubbiah @DrChoueiri @TataMemorial

View quoted post on X

Dr. Karan Sood @QuantumOnc Sep 23

It was a wonderful discussion

Dr Amol Akhade Verified account @SuyogCancer Sep 23

A huge thank you to our incredible faculty @StephenVLiu @LauraAlderMD @TejasPatilMD @g_mountzios @ullas_batra Dr Chandrakanth, Dr Karan Sood for an outstanding #OncoWisdom discussion on What’s New in Lung Cancer from WCLC 2026. 🙏

402 registrations | 160 attendees
Grateful for the time, expertise and honest discussion 🙂.

Thank you for making it special! 🙏

And thank you for all those who attended it . I hope it was useful for all of you 🙂

View quoted post on X